When regulators speak, we listen.Naturally risk-averse industries like the life sciences need health authority acceptance before trying new approaches and especially before committing to wholesale operational change, even if the outcome has great potential.Consider decentralized clinical trials (DCTs) - a new model for conducting research.
[
add
]
[
|
|
...
]